Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30140% above fair value
$25.97−0.45 (-1.70%)
Close on Nov 17, 2026Market cap $996.68MP/E –Yield –
Ceribell operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Ceribell's operating cash flow for the twelve months ending Jun 30, 2026 was -$54.03M. For fiscal 2025 it was -$40.81M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$40.81M | – |
| FY2024 | Dec 31, 2024 | -$35.04M | – |
| FY2023 | Dec 31, 2023 | -$29.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.86M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.30M | – |
| Q4 FY2025 | Dec 31, 2025 | -$10.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.10M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.53M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.98M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.54M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.98M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.55M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.68M | – |
See a number that looks wrong?